Related Experiment Videos
Differential gender differences in ischemic and nephrotoxic acute renal failure
Qingqing Wei1, Mong-Heng Wang, Zheng Dong
1Department of Cellular Biology and Anatomy, Medical College of Georgia, 1459 Laney Walker Boulevard, Augusta, GA 30912, USA.
American Journal of Nephrology
|September 13, 2005
Summary
Female mice resist ischemic acute renal failure (ARF) but are more susceptible to cisplatin-induced ARF. Understanding these sex differences in ARF is crucial for developing targeted treatments.
Area of Science:
- Nephrology
- Renal Physiology
- Toxicology
Background:
- Female animals exhibit greater resistance to ischemic acute renal failure (ARF) compared to males.
- The underlying mechanisms for this observed gender disparity in ARF remain largely unknown.
- It is unclear if this protective effect in females extends to ARF induced by non-ischemic insults.
Purpose of the Study:
- To investigate and delineate the gender-specific differences in response to both ischemic and nephrotoxic forms of ARF.
- To compare the outcomes of ARF in male and female mice across different etiological models.
Main Methods:
- Two distinct experimental models of ARF were employed: ischemic ARF induced by renal pedicle clamping and reperfusion, and nephrotoxic ARF induced by cisplatin administration.
- Key parameters assessed included renal function markers (serum creatinine, blood urea nitrogen), histological evidence of renal tissue damage, animal survival rates, and cellular apoptosis.
- Experiments were conducted using C57BL/6 and 129/Sv mouse strains.
Main Results:
- Female mice demonstrated significantly improved outcomes in ischemic ARF, characterized by lower serum creatinine and blood urea nitrogen levels, reduced renal tissue damage, decreased apoptosis, and enhanced survival rates.
- Conversely, female mice exhibited increased sensitivity to cisplatin-induced ARF, with earlier and more pronounced elevations in blood urea nitrogen and serum creatinine.
- Histological analysis revealed more severe tubular necrosis in female mice following cisplatin exposure, despite similar levels of apoptosis and caspase activation between genders, with males showing better survival in this model.
Conclusions:
- This study reveals a dichotomy in gender-specific responses to ARF, with females being protected against ischemic injury but more vulnerable to nephrotoxic insults.
- The findings highlight the critical role of sex as a biological variable in ARF pathogenesis.
- Further investigation into the cellular and molecular mechanisms underlying these sex-based differences is warranted for potential therapeutic strategies.